Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...